Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51301-51350 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04772300
Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease
NARecruiting
230 participants
Started: Feb 10, 2022 · Completed: Sep 30, 2028
1 condition5 sponsors23 locations
NCT05218226
Avatrombopag for Chemotherapy-induced Thrombocytopenia
PHASE2Recruiting
50 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
2 conditions7 sponsors1 location
NCT05643079
Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw
N/ARecruiting
40 participants
Started: Feb 10, 2022 · Completed: Feb 29, 2028
4 conditions1 sponsor1 location
NCT05062707
Early Ageing During Therapy in AYA Cancer Patients
N/ARecruiting
120 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2025
8 conditions2 sponsors1 location
NCT05125029
Botulinum Toxin in Raynaud's Phenomenon
PHASE4Recruiting
36 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04779320
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
PHASE3Recruiting
120 participants
Started: Feb 10, 2022 · Completed: May 22, 2026
1 condition1 sponsor96 locations
NCT04661280
Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
PHASE3Recruiting
240 participants
Started: Feb 10, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06273748
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
N/ARecruiting
290 participants
Started: Feb 10, 2022 · Completed: May 2, 2032
1 condition1 sponsor5 locations
NCT05319678
Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users
N/ARecruiting
80 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05136664
Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
PHASE3Recruiting
290 participants
Started: Feb 10, 2022 · Completed: Nov 30, 2025
2 conditions2 sponsors29 locations
NCT05228951
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
PHASE2Recruiting
12 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04542148
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
PHASE2Recruiting
120 participants
Started: Feb 10, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor4 locations
NCT06240468
Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort Study
N/ARecruiting
2,000 participants
Started: Feb 10, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05228041
BIOlogics in Severe Nasal POlyposis SurvEy
N/ARecruiting
100 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05323201
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
PHASE1/PHASE2Recruiting
15 participants
Started: Feb 10, 2022 · Completed: Feb 10, 2027
1 condition3 sponsors1 location
NCT05769699
Serum Biomarkers in Parkinson's Disease at Different Stages
NARecruiting
200 participants
Started: Feb 10, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05233722
mTOR as Mediator of Insulin Sensitivity Study
NARecruiting
10 participants
Started: Feb 10, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT05091684
Administration of Fibrinogen Concentrate for Refractory Bleeding
PHASE2Recruiting
10 participants
Started: Feb 10, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT06479018
Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid
NARecruiting
140 participants
Started: Feb 10, 2022 · Completed: Jan 10, 2026
1 condition1 sponsor1 location
NCT05263219
DEB-TACE+HAIC vs. HAIC for Large HCC
PHASE3Recruiting
230 participants
Started: Feb 10, 2022 · Completed: Feb 9, 2026
1 condition8 sponsors1 location
NCT06094257
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
N/ARecruiting
400 participants
Started: Feb 9, 2022 · Completed: Mar 31, 2033
9 conditions2 sponsors2 locations
NCT04862221
TReatment for ImmUne Mediated PathopHysiology
PHASE2Recruiting
163 participants
Started: Feb 9, 2022 · Completed: May 31, 2027
5 conditions2 sponsors23 locations
NCT05080673
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NARecruiting
9,500 participants
Started: Feb 9, 2022 · Completed: Nov 1, 2065
2 conditions2 sponsors466 locations
NCT05268887
High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease
NARecruiting
40 participants
Started: Feb 9, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04905810
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
PHASE2Recruiting
20 participants
Started: Feb 9, 2022 · Completed: Dec 1, 2025
2 conditions3 sponsors4 locations
NCT05329480
Cardiac and Vascular Responses to Creatine Supplementation in Elderly Men
NARecruiting
45 participants
Started: Feb 9, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05230225
Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: The DETECT AS Trial
NARecruiting
940 participants
Started: Feb 9, 2022 · Completed: Feb 15, 2026
1 condition2 sponsors1 location
NCT04564976
Social Support and Reduced Fear Acquisition
NARecruiting
100 participants
Started: Feb 9, 2022 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT04527419
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NARecruiting
545 participants
Started: Feb 9, 2022 · Completed: Feb 9, 2027
1 condition1 sponsor1 location
NCT04807816
Targeting ATR in Soft-tissue Sarcomas
PHASE2Recruiting
72 participants
Started: Feb 9, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors6 locations
NCT03786003
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NARecruiting
1,086 participants
Started: Feb 9, 2022 · Completed: Feb 9, 2028
1 condition1 sponsor1 location
NCT06591390
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
PHASE3Recruiting
900 participants
Started: Feb 9, 2022 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT06008847
Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis Study
N/ARecruiting
674 participants
Started: Feb 9, 2022 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT05072977
Photorefractive Keratectomy (PRK) : Comparison of Corneal Haze Between Two Modes of De-epithelialisation (Laser Versus Manual Alcohol)
NARecruiting
71 participants
Started: Feb 9, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05802680
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
NARecruiting
500 participants
Started: Feb 9, 2022 · Completed: Feb 1, 2027
5 conditions1 sponsor1 location
NCT05327387
Model-based Electrical Brain Stimulation
NARecruiting
25 participants
Started: Feb 8, 2022 · Completed: Mar 31, 2026
1 condition3 sponsors2 locations
NCT05305898
"MetCool ACS- Metformin Cooling Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome"
PHASE3Recruiting
2,000 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors14 locations
NCT05246475
Measurement of Head and Neck Tumor Hypoxia With PET-MRI
NARecruiting
30 participants
Started: Feb 8, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05245734
Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women
PHASE4Recruiting
281 participants
Started: Feb 8, 2022 · Completed: Apr 30, 2025
1 condition3 sponsors16 locations
NCT04920539
In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
PHASE1Recruiting
40 participants
Started: Feb 8, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT05171660
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
PHASE3Recruiting
446 participants
Started: Feb 8, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05150457
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
PHASE1Recruiting
48 participants
Started: Feb 8, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor3 locations
NCT05050799
US Post-Market Surveillance Study of the Surfacer System
N/ARecruiting
30 participants
Started: Feb 8, 2022 · Completed: Dec 15, 2026
1 condition1 sponsor6 locations
NCT05074277
Skeletal Response to Simulated Night Shift
NARecruiting
20 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05655260
PErsonalized TReatment for Endometrial Carcinoma
NARecruiting
300 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2028
1 condition8 sponsors1 location
NCT05264857
Decision Aid and Thyroid Nodules Management
NARecruiting
134 participants
Started: Feb 8, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05157932
An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation
NARecruiting
40 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05024318
NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
PHASE2Recruiting
20 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05246527
Acute Effects of Physical Exercise in Patients with Borderline Personality Disorder
NARecruiting
120 participants
Started: Feb 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05085288
The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial
NARecruiting
1,100 participants
Started: Feb 8, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor3 locations